March 14, 2022A $1.57 million grant from the Department of Army, U.S. Army Medical Research Acquisition Activity, will help support a transformative approach for breast cancer treatment developed by scientists in Mason’s Center for Drug Discovery for Rare Diseases.
New research led by George Mason University’s College of Health and Human Services faculty Dr. Michelle Williams assessed African American breast cancer survivors’ risk factors and knowledge about cardiovascular disease in the Deep South. They found that although African American breast cancer survivors have a higher prevalence of CVD risk factors, their knowledge about CVD is low.